Calling all healthtech founders: Your data strategy can make or break a deal
Private equity and venture capital interest in healthtech has surged and activity shows no sign of abating this year.
But some investors are learning the hard way that a glossy pitch deck and polished paperwork are not enough to secure funding, especially when a company’s value hinges on access to sensitive health data, such as biometric scans, genetic profiles, mental health logs and daily activity tracking.
Print and share
Authors
Notice
Before proceeding, please note: If you are not a current client of Perkins Coie, please do not include any information in this e-mail that you or someone else considers to be of a confidential or secret nature. Perkins Coie has no duty to keep confidential any of the information you provide. Neither the transmission nor receipt of your information is considered a request for legal advice, securing or retaining a lawyer. An attorney-client relationship with Perkins Coie or any lawyer at Perkins Coie is not established until and unless Perkins Coie agrees to such a relationship as memorialized in a separate writing.